Table 1.
Demographic and Clinical Characteristics of the Study Sample
| Whole Sample (N = 34) | Previous COVID-19 (n = 24) | Naïve (n = 10) | P Value | |
|---|---|---|---|---|
| Age | ||||
| Mean | 74.3 | 72.3 | 79.3 | .58 |
| SD | 9.1 | 1.6 | 3.1 | |
| Sex | ||||
| Female | 22 (65%) | 15 | 7 | .68 |
| Male | 12 (35%) | 9 | 3 | |
| Comorbidities | ||||
| Dementia | 21 (62%) | 13 | 8 | .16 |
| Arterial Hypertension | 12 (35%) | 8 | 4 | .71 |
| Chronic obstructive pulmonary disease | 8 (23%) | 6 | 2 | .75 |
| Cardiomyopathy ischemic | 7 (21%) | 3 | 4 | .07 |
| Peripheral arterial disease | 7 (21%) | 6 | 1 | .32 |
| Diabetes | 4 (12%) | 3 | 1 | .84 |
| Obesity | 4 (12%) | 3 | 1 | .84 |
| Cardiac failure | 2 (6%) | 1 | 1 | .51 |
| Stroke | 2 (6%) | 1 | 1 | .51 |
| Chronic renal Failure | 1 (3%) | 1 | 0 | .51 |